Human Umbilical Cord Mesenchymal Stem Cell–Derived Exosomes Attenuate Renal Fibrosis by Suppressing Fibroblast Activation via the INHBA/PI3K/AKT Pathway
Pediatric Discovery · 29.06.2026
DOI: 10.1002/pdi3.70061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Discovery, online erschienen am 29.06.2026. Verfasst von Meiling Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Education Key Laboratory of Child Development and Disorders, Department of Urology Children's Hospital of Chongqing Medical University, N…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Renal fibrosis is a common pathological feature and key driver of progression to end‐stage renal disease in various chronic kidney diseases, with effective treatments remaining scarce. Exosomes derived from mesenchymal stem cells (MSC‐Exos) have demonstrated tremendous potential in tissue and organ repair and antifibrosis treatment. This study investigated the therapeutic effects and mechanisms of MSC‐Exo derived from human umbilical cord (HucMSC‐Exo) on renal fibrosis. HucMSC‐Exo was applied to intervene in a mouse model of renal fibrosis induced by unilateral ureteral obstruction (UUO) or cocultured with TGF‐β‐stimulated rat renal fibroblasts (NRK‐49F). Results showed that HucMSC‐Exo conspicuously alleviated pathological damage, inflammatory response, fibroblast proliferation/activation, and extracellular matrix deposition in UUO kidneys. Single‐cell sequencing revealed a prominent upregulation of Inhba gene in UUO kidneys, whereas HucMSC‐Exo treatment effectively inhibited its expression. Further mechanistic studies showed that knocking down Inhba mimicked the antifibrotic effects of HucMSC‐Exo, whereas exogenously adding INHBA weakened its protective effects. Transcriptome sequencing results revealed that the downstream effects of Inhba involve regulating the PI3K/AKT signaling pathway, and HucMSC‐Exo treatment markedly inhibited the activation of this pathway. Collectively, HucMSC‑Exo exerts antifibrotic effects by regulating the INHBA/PI3K/AKT signaling axis to inhibit renal fibroblast activation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ministry of Education Key Laboratory of Child Development and Disorders, Department of Urology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders Chongq…
- Chongqing Key Laboratory of Structural Birth Defect and Reconstruction Chongqing China.
- Children Urogenital Development and Tissue Engineering of Chongqing Education Commission of China Chongqing China.
- Department of Pediatric Urology West China Second University Hospital, Sichuan University Chengdu Sichuan China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education Chengdu Sichuan China.
- Center for Bio-Intelligent Manufacturing and Living Matter Bioprinting Research Institute of Tsinghua University in Shenzhen, Tsinghua University Shenzhen Guangdong China.
ORCID-Profile: Deying Zhang
Zitieren
APA
Chen, M., Jia, C., Shi, Z., Zhu, B., Yu, Y., Liu, X., Liu, F., Chen, J., Xu, T., Zhang, Y., Zhang, D., & Wei, G. (2026). Human Umbilical Cord Mesenchymal Stem Cell–Derived Exosomes Attenuate Renal Fibrosis by Suppressing Fibroblast Activation via the INHBA/PI3K/AKT Pathway. Pediatric Discovery. https://doi.org/10.1002/pdi3.70061
Vancouver
Chen M, Jia C, Shi Z, Zhu B, Yu Y, Liu X, et al. Human Umbilical Cord Mesenchymal Stem Cell–Derived Exosomes Attenuate Renal Fibrosis by Suppressing Fibroblast Activation via the INHBA/PI3K/AKT Pathway. Pediatric Discovery. 2026. doi:10.1002/pdi3.70061
BibTeX
@article{Chen2026,
author = {Chen, Meiling and Jia, Chenxi and Shi, Zhuocheng and Zhu, Bianan and Yu, Yihang and Liu, Xing and Liu, Feng and Chen, Jianwei and Xu, Tao and Zhang, Yuanyuan and Zhang, Deying and Wei, Guanghui},
title = {Human Umbilical Cord Mesenchymal Stem Cell–Derived Exosomes Attenuate Renal Fibrosis by Suppressing Fibroblast Activation via the INHBA/PI3K/AKT Pathway},
journal = {Pediatric Discovery},
year = {2026},
doi = {10.1002/pdi3.70061}
}
EUVIMED